Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG Requirements
Published: | Updated:
Rise in demand for sustainable practices forces industry to be more proactive.
Rashida Salahuddin
Advertisement
President and CEO, The Corporate Citizenship Project
Articles by Rashida Salahuddin
Advertisement
Latest Updated Articles
Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG RequirementsPublished: May 3rd 2022 | Updated: February 13th 2025
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
4
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
5